Lp A-I and niacin: new views of an antiatherogenic duo.
Saucan
L
L
Brinton
E A
EA
D016632:Apolipoprotein A-I / Q000378:metabolism*; D016633:Apolipoprotein A-II / Q000378:metabolism; D001161:Arteriosclerosis / Q000188:drug therapy / Q000378:metabolism*; D008076:Cholesterol, HDL / Q000378:metabolism; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008075:Lipoproteins, HDL / Q000378:metabolism; D009525:Niacin / Q000494:pharmacology*
D016632:Apolipoprotein A-I; D016633:Apolipoprotein A-II; D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D008075:Lipoproteins, HDL; D009525:Niacin